Cargando…

A New Possible Cut-Off of Cytokeratin 19 mRNA Copy Number by OSNA in the Sentinel Node of Breast Cancer Patients to Avoid Unnecessary Axillary Dissection: A 10-Year Experience in a Tertiary Breast Unit

SIMPLE SUMMARY: This manuscript aims to investigate the features of patients with metastatic sentinel lymph node (SLN), evaluated by OSNA, and to predict which patients have a high risk of positive ALND. The finding of the present study suggests a new cut-off of CK19 mRNA copy number in the sentinel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomasicchio, Giovanni, Mastropasqua, Mauro Giuseppe, Picciariello, Arcangelo, Montanaro, Alda Elena, Signorile, Daniela, Cirilli, Alfredo, Punzo, Clelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318019/ https://www.ncbi.nlm.nih.gov/pubmed/35884447 http://dx.doi.org/10.3390/cancers14143384

Ejemplares similares

Osteoclast-like stromal giant cells in invasive ductal breast cancer: A case series
por: Angellotti, Giustina, et al.
Publicado: (2022)

Intraoperative Sentinel Lymph Node Evaluation: Implications of Cytokeratin 19 Expression for the Adoption of OSNA in Oral Squamous Cell Carcinoma
por: Shaw, Richard, et al.
Publicado: (2016)

Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery
por: Stovgaard, Elisabeth Specht, et al.
Publicado: (2012)

An improved axillary staging system using the OSNA assay does not modify the therapeutic management of breast cancer patients
por: Ruano, Miguel Alonso, et al.
Publicado: (2014)

One-Step Nucleic Acid Amplification (OSNA) of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Spanish Multicenter Study (ENDO-OSNA)
por: Diestro, María Dolores, et al.
Publicado: (2021)

Intraoperative diagnosis of sentinel lymph node metastases in breast cancer treatment with one-step nucleic acid amplification assay (OSNA)
por: Szychta, Paweł, et al.
Publicado: (2016)

A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients
por: Terrenato, Irene, et al.
Publicado: (2017)

Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients
por: van Haaren, Elisabeth R. M., et al.
Publicado: (2023)

Axillary Treatment Management in Breast Cancer during COVID-19 Pandemic (Association between ACOSOG Z0011 Criteria and OSNA Test)
por: Anedda, Giacomo, et al.
Publicado: (2023)

Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
por: TAKAMARU, TOMOKO, et al.
Publicado: (2014)

Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer
por: Peña, Karla B., et al.
Publicado: (2021)

Advantages of one step nucleic acid amplification (OSNA) whole node assay in sentinel lymph node (SLN) analysis in breast cancer
por: Santaballa, Ana, et al.
Publicado: (2013)

Application of OSNA Nomogram in Patients With Macrometastatic Sentinel Lymph Node: A Retrospective Assessment of Accuracy
por: Combi, Francesca, et al.
Publicado: (2021)

Avoiding unnecessary sentinel node biopsy
por: Jeffree, JS, et al.
Publicado: (2006)

Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA
por: Vilardell, Felip, et al.
Publicado: (2012)

OSNA Total Tumor Load for the Prediction of Axillary Involvement in Breast Cancer Patients: Should We use Different Thresholds According to the Intrinsic Molecular Subtype? MOTTO Study
por: Bernet, L, et al.
Publicado: (2023)

Concomitant Activation of OsNAS2 and OsNAS3 Contributes to the Enhanced Accumulation of Iron and Zinc in Rice
por: Lee, Sichul, et al.
Publicado: (2023)

Avoiding unnecessary intraoperative sentinel lymph node frozen section biopsy of patients with early breast cancer
por: Kang, Jongwon, et al.
Publicado: (2022)

Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Kristen, P, et al.
Publicado: (2005)

Preoperative sonographic axillary staging in breast cancer: correlation with sentinel node sampling
por: Sankaye, P, et al.
Publicado: (2011)

Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node
por: Shojaee, Leyla, et al.
Publicado: (2020)

Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
por: Reimer, Toralf
Publicado: (2023)

Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases
por: Zheng, Jianwei, et al.
Publicado: (2018)

Reply: Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Reitsamer, R, et al.
Publicado: (2005)

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients
por: Tanis, P J, et al.
Publicado: (2002)

Sentinel node biopsy should be supplemented by axillary sampling in patients with small breast cancers
por: Adwani, A, et al.
Publicado: (2005)

Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline E. F., et al.
Publicado: (2023)

Immunohistochemical detection of axillary lymph node micrometastases in node negative breast cancer patients using cytokeratin and epithelial membrane antigen
por: Choudhury, Monisha, et al.
Publicado: (2015)

Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
por: Zavagno, Giorgio, et al.
Publicado: (2005)

Breast metastasis of primary colon cancer with micrometastasis in the axillary sentinel node: A metastasis that metastasized?
por: Perin, Tiziana, et al.
Publicado: (2011)

The Axillary Nodal Harvest in Breast Cancer Surgery Is Unchanged by Sentinel Node Biopsy or the Timing of Surgery
por: Byrne, B. E., et al.
Publicado: (2012)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy
por: Cao, Xiao-Shan, et al.
Publicado: (2016)

Occult metastatic thyroid cancer diagnosed during breast cancer axillary sentinel node biopsy
por: Herle, Pratima, et al.
Publicado: (2020)

Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer
por: Rukanskienė, Dalia, et al.
Publicado: (2020)

Axillary management in early breast cancer with onset surgical management and positive sentinel lymph node
por: Vasquez, Lia Pamela Rebaza, et al.
Publicado: (2021)

Survival and recurrence with or without axillary dissection in patients with invasive breast cancer and sentinel node metastasis
por: Sanvido, Vanessa Monteiro, et al.
Publicado: (2021)

Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis
por: Gou, Zongchao, et al.
Publicado: (2022)

Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients
por: Murawski, Marek, et al.
Publicado: (2016)

The competent sentinel node: an association with an axillary presentation and an occult or a small primary invasive breast carcinoma
por: Mansfield, Lucy, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_h5vfm3f59585vihhp3dbo11g2p